FDA Approves First Drug to Treat Genetic Mutation Causing Dwarfism

Food and Drug Administration (FDA) recently approved Voxzogo, also known by the generic name vosoritide, as the first injectable drug to treat dwarfism (achondroplasia). The agency approved the drug for use in children ages five and up. Theresa Kehoe, director of FDA’s Division of General Endocrinology, said that the approval fulfills an unmet medical need for […]

The post FDA Approves First Drug to Treat Genetic Mutation Causing Dwarfism appeared first on Guardian Liberty Voice.